Gopala Krishna Mannala

Multiple drug-resistant bacteria are a growing life-threatening problem and novel treatment strategies are urgently needed. One promising option is the use of lytic bacteriophages, viruses that infect and kill bacteria with high specificity. To efficiently utilize bacteriophage therapy for the treatment of implant-associated infections, an effective strategy for the local, long-lasting administration of bacteriophages at the site of infection is required.

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.